ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.23
-0.90%
US Tech 100
18,508.00
-0.14%
S&P 500
5,350.57
-0.04%
US Dollar vs CAD
1.37548
0.63%
Bitcoin
69,293.31
-2.07%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anixa Biosciences Inc (ANIX)

  7. Anixa Biosciences Inc (ANIX) News

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIX
DateTimeSourceHeadlineSymbolCompany
06/07/202411:24AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
06/07/20249:57AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
06/04/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
05/21/20246:30AMPR Newswire (US)Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
05/08/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
05/08/20247:25AMPR Newswire (US)Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesNASDAQ:ANIXAnixa Biosciences Inc
05/06/20247:05AMPR Newswire (US)Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaNASDAQ:ANIXAnixa Biosciences Inc
04/30/20246:45AMPR Newswire (US)Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024NASDAQ:ANIXAnixa Biosciences Inc
04/18/20247:20AMPR Newswire (US)Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
03/14/20247:45AMPR Newswire (US)Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesNASDAQ:ANIXAnixa Biosciences Inc
03/11/20247:00AMPR Newswire (US)Anixa Biosciences Announces Presentation at 24th Annual World Vaccine CongressNASDAQ:ANIXAnixa Biosciences Inc
02/12/20246:30AMPR Newswire (US)Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
02/08/20243:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIXAnixa Biosciences Inc
01/29/20247:50AMPR Newswire (US)Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology ConferenceNASDAQ:ANIXAnixa Biosciences Inc
01/23/20246:55AMPR Newswire (US)Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
01/16/20246:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
01/16/20246:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
01/16/20246:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
01/16/20246:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
01/16/20246:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
01/16/20244:29PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIXAnixa Biosciences Inc
01/16/20243:43PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIXAnixa Biosciences Inc
01/16/20243:30PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIXAnixa Biosciences Inc
01/10/20248:00AMPR Newswire (US)Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024NASDAQ:ANIXAnixa Biosciences Inc
12/14/20236:15AMPR Newswire (US)Anixa Biosciences to Present at Biotech Showcase 2024NASDAQ:ANIXAnixa Biosciences Inc
12/07/20235:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
12/06/20235:00PMPR Newswire (US)Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
12/06/20233:05PMPR Newswire (US)Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
11/27/20237:30AMPR Newswire (US)Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
11/02/20239:58AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ANIX

Your Recent History

LSE
IMEU
Ishr Msci Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved